| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/26/2009 | WO2009026151A2 Process for producing zein articles with limited solubility |
| 02/26/2009 | WO2009026089A1 Methods and compositions for targeting proteins of interest to the host cell envelope |
| 02/26/2009 | WO2009026053A2 Inhibitors of iaspp interaction with an iaspp binding partner and methods of use |
| 02/26/2009 | WO2009025957A1 Erythropoietin receptor peptide formulations and uses |
| 02/26/2009 | WO2009025871A1 Telomerase reverse transcriptase variant |
| 02/26/2009 | WO2009025846A2 Activatable binding polypeptides and methods of identification and use thereof |
| 02/26/2009 | WO2009025759A1 Tight junction proteins associated with infection and entry of hepatitis c virus (hcv), methods and uses thereof |
| 02/26/2009 | WO2009025754A2 Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i |
| 02/26/2009 | WO2009025300A1 Peptide capable of binding to immunoglobulin |
| 02/26/2009 | WO2009025149A1 Adnf receptor |
| 02/26/2009 | WO2009025116A1 Cdh3 peptide and medicinal agent comprising the same |
| 02/26/2009 | WO2009025080A1 Colorectal cancer marker polypeptide, and method for diagnosis of colorectal cancer |
| 02/26/2009 | WO2009024986A2 Regulatory sequences derived from il-10 promoter and uses thereof in modulation of immune response |
| 02/26/2009 | WO2009024862A2 Process |
| 02/26/2009 | WO2009024789A1 Hiv-2 antigenic peptides |
| 02/26/2009 | WO2009024736A1 Protein |
| 02/26/2009 | WO2009024726A2 Method for purifying or detecting a target protein |
| 02/26/2009 | WO2009024620A2 A process for isolation and purification of a target protein free of prion protein (prpsc) |
| 02/26/2009 | WO2009024572A1 Method for the production of modified steroid degrading microorganisms and their use |
| 02/26/2009 | WO2009024534A2 Japanese encephalitis virus (jev) and tick-borne encephalitis virus (tbev) peptides stimulating human t cell responses |
| 02/26/2009 | WO2009024531A1 Method for treating and diagnosing hematologic malignancies |
| 02/26/2009 | WO2009024528A1 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 02/26/2009 | WO2009024327A2 New proteins for use in human and animal staphylococcus infections |
| 02/26/2009 | WO2009024280A2 Cell carrier containing collagen |
| 02/26/2009 | WO2009024208A1 Hypoallergenic molecules |
| 02/26/2009 | WO2009024142A2 Protease-stable, cell wall-lysing enzymes |
| 02/26/2009 | WO2009023995A1 Crystal structure of cd147 extracellular region and use thereof |
| 02/26/2009 | WO2009023961A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/26/2009 | WO2009023959A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 02/26/2009 | WO2009023955A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 02/26/2009 | WO2009009493A3 Aegyptin and uses thereof |
| 02/26/2009 | WO2009009034A3 Methods and compositions useful in the treatment of mucositis |
| 02/26/2009 | WO2009006638A3 Peptides facilitating retrograde transport and their uses |
| 02/26/2009 | WO2009006301A3 Protein stabilization |
| 02/26/2009 | WO2009004054A3 A cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide |
| 02/26/2009 | WO2009003493A3 Mhc multimers, methods for their generation, labeling and use |
| 02/26/2009 | WO2009000929A3 Composition and method for treatment of autoimmune disease |
| 02/26/2009 | WO2009000891A3 Linear expression constructs for production of influenza virus particles |
| 02/26/2009 | WO2008157378A3 Rage fusion proteins |
| 02/26/2009 | WO2008154547A3 Spider silk dragline polynucleotides, polypeptides and methods of use thereof |
| 02/26/2009 | WO2008154516A3 Btnl2 fusion protein for t-cell activity modulation |
| 02/26/2009 | WO2008152652A3 A dengue envelope domain iii-based tetravalent protein vaccine |
| 02/26/2009 | WO2008152262A3 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system |
| 02/26/2009 | WO2008152140A3 Recombinant transferrin mutants |
| 02/26/2009 | WO2008142364A3 Rhd6 and its use in modulating plant root hair development |
| 02/26/2009 | WO2008142163A3 Plants having enhanced yield-related traits and a method for making the same |
| 02/26/2009 | WO2008136736A3 Immunoregulatory structures from normally occurring proteins |
| 02/26/2009 | WO2008130635A3 Formation of superfibronectin by bbk32 and uses therefor |
| 02/26/2009 | WO2008127711A3 Interferons of rhesus and cynomolgus origin and uses thereof |
| 02/26/2009 | WO2008125972A3 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases |
| 02/26/2009 | WO2008116472A3 A method for introducing changes into a eukaryotic genome in vivo using hpv |
| 02/26/2009 | WO2008109653A3 Peptides specific for human blood outgrowth endothelial cells |
| 02/26/2009 | WO2008105901A3 Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity |
| 02/26/2009 | WO2008094538A3 Regulatory t cell epitopes, compositions and uses thereof |
| 02/26/2009 | WO2008091531A3 Elements for improved expression of bovine somatotropin |
| 02/26/2009 | WO2008089144A3 Improved dna vaccination protocols |
| 02/26/2009 | WO2008070357A3 Smoothened polypeptides and methods of use |
| 02/26/2009 | WO2008059041A3 Complementation of factor xi deficiency by factor v mutants |
| 02/26/2009 | WO2008059009A3 Factor v mutants for hemostasis in hemophilia |
| 02/26/2009 | WO2008057461A3 Alk1 receptor and ligand antagonists and uses thereof |
| 02/26/2009 | WO2007146401A3 Denatured collagen peptides and uses thereof |
| 02/26/2009 | WO2006086150A3 Phuman t2r receptors for acetaminophen, ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators |
| 02/26/2009 | WO2005116260A3 Influenza hemagglutinin and neuraminidase variants |
| 02/26/2009 | WO2004096160A3 Vesicle-associated proteins |
| 02/26/2009 | WO2002033046A3 Glucose transport-related genes and uses thereof |
| 02/26/2009 | US20090055973 Novel Omega-3 Fatty Acid Desaturase Family Members and Uses Thereof |
| 02/26/2009 | US20090055971 Plant having enhanced root elongation and method for production thereof |
| 02/26/2009 | US20090055967 Polynucleotides and polypeptides involved in post-transcriptional gene silencing |
| 02/26/2009 | US20090055942 Human Coagulation Factor VII Polypeptides |
| 02/26/2009 | US20090055940 Zebrafish model of mll leukemogenesis |
| 02/26/2009 | US20090054633 Method for Controlling Stability of Nanofabricated Polypeptide Multilayer Films, Coatings, and Microcapsules |
| 02/26/2009 | US20090054632 Hydrophobically-modified protein compositions and methods |
| 02/26/2009 | US20090054629 Inhibitors of Transthyretin Amyloid Fibril Formation |
| 02/26/2009 | US20090054628 Method and system for in vitro protein folding |
| 02/26/2009 | US20090054626 Crustacean-derived protein having antifreeze activity |
| 02/26/2009 | US20090054625 Recombinant protein variants |
| 02/26/2009 | US20090054624 useful in the treatment of a condition which is responsive to the PRO polypeptide, an agonist or antagonist thereof or an anti-PRO antibody |
| 02/26/2009 | US20090054622 Peptide variants of the tumor marker MUC1 and their application |
| 02/26/2009 | US20090054560 Method for preparing solid materials comprising immobilized proteorhodopsin |
| 02/26/2009 | US20090054367 Mycobacterial antigens expressed under low oxygen tension |
| 02/26/2009 | US20090054361 Pot1 alternative splicing variants |
| 02/26/2009 | US20090054344 Anti-angiogenic proteins and fragments and methods of use thereof |
| 02/26/2009 | US20090054342 Bioactive peptides and method of using same |
| 02/26/2009 | US20090054337 Natriuretic polypeptides |
| 02/26/2009 | US20090054336 Binding Agent |
| 02/26/2009 | US20090054335 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells |
| 02/26/2009 | US20090054333 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
| 02/26/2009 | US20090054332 Thombopoietin peptide conjugates |
| 02/26/2009 | US20090054327 Human immunodeficiency virus transactivator protein (HIV-TAT)-utrophin fusion for use in treatment of muscular disorders |
| 02/26/2009 | US20090054325 Compositions and methods for suppressing axonal growth inhibition |
| 02/26/2009 | US20090054324 Transcriptional Regulation of High Affitnity Ige Receptor Gamma-Chain |
| 02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
| 02/26/2009 | US20090054321 Polypeptides and use thereof |
| 02/26/2009 | US20090054320 Vesiculins |
| 02/26/2009 | US20090054316 Agent for control of function of antigen-presenting cell |
| 02/26/2009 | US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders |
| 02/26/2009 | US20090054257 Method of improving t cell receptors |
| 02/26/2009 | US20090054252 Hemopexin-Like Structure as New Polypeptide-Scaffold |
| 02/26/2009 | US20090054248 Connexin 40 tissue specific gene mutations |
| 02/26/2009 | US20090054247 Polynucleotides encoding proteins involved in plant metabolism |